Decarboxylase

所有产品 Decarboxylase抑制剂(7)

目录号	产品描述	文献引用
S1891	Carbidopa Carbidopa 是一种芳香族-L-氨基酸脱羧酶抑制剂，IC50为29±2 μM。	PLoS One, 2017, 12(3):e0173240
S2453	Benserazide HCl Benserazide HCl是一种外周性的芳香族L-氨基酸脱羧酶（AAAD）或DOPA脱羧酶抑制剂。
S1642	Methyldopa Methyldopa 是DOPA 脱羧酶竞争性抑制剂，ED50为21.8 mg/kg。
S4582	Eflornithine hydrochloride hydrate Eflornithine(Difluoromethylornithine)通过对鸟氨酸脱羧酶的不可逆抑制作用，抑制多胺生物合成。它是一种化疗保护剂，可阻止血管生成。其生物半衰期为8小时。	Front Cell Infect Microbiol, 2020, 16;10:158
S5448	S(-)-Carbidopa S(-)-Carbidopa is a peripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism.
S5444	4-Bromo-3-hydroxybenzoic acid 4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase with resultant inhibition of histamine formation in mammals.
S5409	Chelidamic acid hydrate Chelidamic acid is a pharmaceutical intermediate as well as a cosmetic material due to its anti-inflammatory and whitening effect.

目录号	产品描述	文献引用
S1891	Carbidopa Carbidopa 是一种芳香族-L-氨基酸脱羧酶抑制剂，IC50为29±2 μM。	PLoS One,2017, 12(3):e0173240
S2453	Benserazide HCl Benserazide HCl是一种外周性的芳香族L-氨基酸脱羧酶（AAAD）或DOPA脱羧酶抑制剂。
S1642	Methyldopa Methyldopa 是DOPA 脱羧酶竞争性抑制剂，ED50为21.8 mg/kg。
S4582	Eflornithine hydrochloride hydrate Eflornithine(Difluoromethylornithine)通过对鸟氨酸脱羧酶的不可逆抑制作用，抑制多胺生物合成。它是一种化疗保护剂，可阻止血管生成。其生物半衰期为8小时。	Front Cell Infect Microbiol,2020, 16;10:158
S5448	S(-)-Carbidopa S(-)-Carbidopa is a peripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism.
S5444	4-Bromo-3-hydroxybenzoic acid 4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase with resultant inhibition of histamine formation in mammals.
S5409	Chelidamic acid hydrate Chelidamic acid is a pharmaceutical intermediate as well as a cosmetic material due to its anti-inflammatory and whitening effect.